Strong OTC Brand RecognitionAmrutanjan's well-known brand in topical analgesics generates repeat purchase behavior and shelf prominence in OTC channels. That durable brand equity supports pricing, distribution access and customer loyalty, reducing acquisition costs and strengthening long-term revenue resilience.

Consistent Revenue And Profit GrowthThe company has delivered steady revenue and profit expansion over multiple years, supported by Fundamentals showing ~10% revenue growth and ~15% EPS growth. Sustained top-line and earnings growth enables reinvestment in marketing and distribution and underpins long-term cash generation capacity.

Prudent Balance Sheet And LiquidityA low leverage profile and substantial cash reserves provide financial flexibility to fund working capital, absorb shocks, and pursue selective capex or strategic initiatives. Strong equity growth and liquidity reduce refinancing risk and support durable operational continuity.

Bears Say

Margin Volatility And Cost Control ChallengesHistorical swings in EBIT/EBITDA margins indicate the company faces episodic cost pressures or mix shifts. Persistent margin volatility undermines earnings predictability and can constrain ability to commit to long-term investments or consistent shareholder returns if costs or pricing competitiveness worsen.

Inconsistent Free Cash Flow GrowthIrregular free cash flow expansion limits sustained capacity for dividends, buybacks or higher capex. For a consumer healthcare company reliant on steady marketing and distribution spend, inconsistent FCF raises the risk that strategic programs may be underfunded or financed through less optimal means.

Profitability Sensitive To Marketing And Distribution CostsThe business model depends on continued advertising and wide retail/pharmacy distribution. Structural FMCG/OTC competition requires sustained promotion and distribution investment, which can pressure margins and cash flow if input costs rise or marketing effectiveness diminishes over time.

Amrutanjan Health Care Limited News

Amrutanjan Closes Trading Window Ahead of December Quarter Results

Amrutanjan Health Care Limited ( ($IN:AMRUTANJAN) ) has shared an announcement. Amrutanjan Health Care Limited has announced the...

3M ago

AMRUTANJAN FAQ

What was Amrutanjan Health Care Limited’s price range in the past 12 months?

Amrutanjan Health Care Limited lowest stock price was ₹548.05 and its highest was ₹789.95 in the past 12 months.

What is Amrutanjan Health Care Limited’s market cap?

Amrutanjan Health Care Limited’s market cap is ₹16.97B.

When is Amrutanjan Health Care Limited’s upcoming earnings report date?

Amrutanjan Health Care Limited’s upcoming earnings report date is May 21, 2026 which is in 77 days.

How were Amrutanjan Health Care Limited’s earnings last quarter?

Amrutanjan Health Care Limited released its earnings results on Feb 03, 2026. The company reported ₹6.731 earnings per share for the quarter, beating the consensus estimate of N/A by ₹6.731.

Is Amrutanjan Health Care Limited overvalued?

According to Wall Street analysts Amrutanjan Health Care Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Amrutanjan Health Care Limited pay dividends?

Amrutanjan Health Care Limited pays a Quarterly dividend of ₹1 which represents an annual dividend yield of 0.68%. See more information on Amrutanjan Health Care Limited dividends here

What is Amrutanjan Health Care Limited’s EPS estimate?

Amrutanjan Health Care Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Amrutanjan Health Care Limited have?

Amrutanjan Health Care Limited has 29,230,630 shares outstanding.

What happened to Amrutanjan Health Care Limited’s price movement after its last earnings report?

Amrutanjan Health Care Limited reported an EPS of ₹6.731 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.052%.

Which hedge fund is a major shareholder of Amrutanjan Health Care Limited?

Currently, no hedge funds are holding shares in IN:AMRUTANJAN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Amrutanjan Health Care Limited

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons and lotions, body pain gels, and joint muscle sprays, as well as diclofenac, a non-steroidal anti-inflammatory drug. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, South East Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.